Equities

Option Care Health Inc

Option Care Health Inc

Actions
  • Price (USD)31.08
  • Today's Change0.18 / 0.58%
  • Shares traded2.03m
  • 1 Year change-1.11%
  • Beta1.2545
Data delayed at least 15 minutes, as of Apr 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Option Care Health, Inc. is an independent provider of home and alternate site infusion services. The Company’s infusion services include the clinical management of infusion therapy, nursing support and care coordination. It provides a therapy portfolio through its network of 93 full-service pharmacies and 84 stand-alone ambulatory infusion suites. It administers a wide variety of therapies and services, including anti-infectives infusion, heart failure, chronic inflammatory disorders, immunoglobulin infusion, bleeding disorders infusion, nutrition support infusion, neurological disorders, and others. The Company’s home infusion services include medication and supplies for administration and use at home or within one of its ambulatory infusion suites, consultation and education regarding the patient’s condition and the prescribed medication nursing support, clinical monitoring and assistance in monitoring potential side effects, and assistance in obtaining reimbursement.

  • Revenue in USD (TTM)4.30bn
  • Net income in USD267.09m
  • Incorporated1996
  • Employees5.81k
  • Location
    Option Care Health Inc3000 Lakeside Dr, Suite 300NBANNOCKBURN 60015United StatesUSA
  • Phone+1 (312) 940-2443
  • Fax+1 (302) 636-5454
  • Websitehttps://optioncarehealth.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
OPCH:NSQ since
announced
Transaction
value
Amedisys IncDeal withdrawn03 May 202303 May 2023Deal withdrawn-3.57%3.60bn
Revitalized LLCDeal completed01 May 202301 May 2023Deal completed-3.33%12.90m
Data delayed at least 15 minutes, as of Apr 19 2024 21:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Surgery Partners Inc2.74bn-11.90m2.97bn10.50k--1.4911.701.08-0.0974-0.097421.7715.700.404727.435.76261,266.702.001.172.741.6326.7026.334.933.031.572.420.4522--8.039.1478.21--17.41--
Amedisys Inc2.24bn-9.75m2.97bn19.00k--2.78229.691.33-0.3078-0.307868.4532.651.11--7.33117,704.30-0.54197.82-0.705810.3944.3143.63-0.4895.89--10.030.26230.000.5936.11-108.22--14.16--
Progyny Inc1.09bn62.04m3.06bn563.0051.725.5547.642.810.61640.616410.815.741.68--4.521,933,567.009.5511.5013.0016.0221.9421.485.706.64----0.000.0038.3459.52104.35--44.47--
Select Medical Holdings Corp6.66bn234.72m3.39bn38.40k14.002.636.670.50911.891.8953.7610.040.868--7.08173,543.203.904.194.845.4613.9913.984.505.11--3.520.700915.305.225.5753.0311.986.50--
Evolent Health Inc1.96bn-142.26m3.42bn4.70k--3.16--1.74-1.28-1.2817.6510.940.8733--5.60417,850.20-5.03-9.60-6.67-12.5923.4524.50-5.76-13.66--0.26850.3239--45.2625.65-660.71---6.18--
PACS Group Inc-100.00bn-100.00bn3.45bn32.43k------------------------------------------------28.47---25.00------
Radnet Inc1.62bn3.04m3.48bn7.87k52,900.005.1321.952.160.00090.000925.329.280.631--8.64205,364.601.181.241.561.6621.6721.561.881.86--1.470.50510.0013.0510.64-71.42-37.6319.60--
Irhythm Technologies Inc492.68m-123.41m3.49bn2.00k--16.52--7.08-4.04-4.0416.146.791.1211.058.85246,340.50-28.00-21.92-36.04-26.7767.3569.39-25.05-25.752.02-26.910.1426--19.9027.32-6.24--50.82--
CorVel Corp773.52m74.97m3.92bn4.44k53.2016.8138.945.074.324.3244.5313.661.81--8.82174,059.6017.5814.2931.3822.8922.0122.059.698.78----0.000.0011.195.17-0.067815.28-1.01--
Option Care Health Inc4.30bn267.09m5.37bn5.81k20.893.7916.311.251.481.4823.838.141.3613.3311.39740,630.808.443.6310.384.3522.8122.456.212.781.336.880.42770.009.0643.4277.40--24.72--
Acadia Healthcare Company Inc2.93bn-21.67m6.50bn17.00k--2.3155.672.22-0.2432-0.243232.0730.480.5661--8.56172,278.70-0.30272.32-0.35282.64-----0.53475.600.66696.170.3222--12.208.99-107.93--3.34--
Ensign Group Inc3.73bn209.40m6.63bn35.30k31.864.4223.481.783.663.6665.0726.360.9776--8.35105,647.505.506.456.667.8821.6822.325.636.48--39.170.09086.5623.2716.28-6.8028.624.405.02
Encompass Health Corp4.80bn361.60m7.87bn22.36k22.034.7810.511.643.573.4547.3816.430.818--8.36214,761.108.096.3710.217.9495.4595.589.899.16--5.290.541530.7810.412.3441.314.4916.60-10.42
Data as of Apr 19 2024. Currency figures normalised to Option Care Health Inc's reporting currency: US Dollar USD

Institutional shareholders

42.45%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 31 Dec 202319.16m11.05%
The Vanguard Group, Inc.as of 31 Dec 202319.13m11.03%
Wellington Management Co. LLPas of 31 Dec 20237.45m4.29%
SSgA Funds Management, Inc.as of 31 Dec 20235.93m3.42%
Westfield Capital Management Co. LPas of 31 Dec 20234.48m2.58%
Marshall Wace LLPas of 31 Dec 20233.88m2.24%
Geode Capital Management LLCas of 31 Dec 20233.85m2.22%
UBS Asset Management Switzerland AGas of 31 Dec 20233.68m2.12%
Dimensional Fund Advisors LPas of 31 Dec 20233.19m1.84%
Fidelity Management & Research Co. LLCas of 31 Dec 20232.89m1.67%
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.